A Phase 1 Study of a Single Dose of a Subcutaneous TE-8214 Solution in Healthy Volunteers
Conditions: Acromegaly Interventions: Drug: TE-8214 Cohort 1; Drug: TE-8214 Cohort 2; Drug: TE-8214 Cohort 3; Drug: TE-8214 Cohort 4; Drug: TE-8214 Cohort 5 (optional); Drug: Placebo Sponsors: Immunwork, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
A Phase 1 Study of TE-8214 Solution in Healthy Volunteers
Conditions: Acromegaly Interventions: Drug: TE-8214 - SAD; Drug: Placebo Sponsors: Immunwork, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
Cellular, Molecular and Clinical Determinants of Bone Strength in in Vivo and Human Models of GH Excess. Cross-sectional and Prospective Study
Conditions: Acromegaly; Bone Fracture Interventions: Procedure: Blood sample Sponsors: IRCCS San Raffaele; Fondazione Policlinico Universitario Campus Bio-Medico; Istituto Auxologico Italiano Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2024 Category: Research Source Type: clinical trials
A Study to Understand Participant's Experiences in Gastro-enteropancreatic Neuroendocrine Tumors (GEP-NETs) and Acromegaly
Conditions: Gastro-enteropancreatic Neuroendocrine Tumor; Acromegaly Sponsors: Ipsen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials
Effects of Therapies in the Acromegaly Disease: Acral Morpho-functional Study
Condition: Acromegaly Intervention: Procedure: Medical surgery therapy Sponsors: Istituto Auxologico Italiano; Politecnico di Milano Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2023 Category: Research Source Type: clinical trials
A Single-dose Study of Octreotide Injection in Healthy Adult Subjects
Condition: Acromegaly Interventions: Drug: SYHX2008 injection; Drug: Octreotide Acetate Microspheres for Injection injection; Drug: Sandostatin ® injection; Drug: Placebo to SYHX2008 injection Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 9, 2023 Category: Research Source Type: clinical trials
A Single-dose Study of Octreotide Injection in Healthy Adult Subjects
Condition: Acromegaly Interventions: Drug: SYHX2008 injection; Drug: Octreotide Acetate Microspheres for Injection injection; Drug: Sandostatin ® injection; Drug: Placebo to SYHX2008 injection Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 9, 2023 Category: Research Source Type: clinical trials
